NYSE American - Delayed Quote USD

Catheter Precision, Inc. (VTAK)

0.1849
-0.0038
(-2.01%)
At close: May 30 at 4:00:00 PM EDT
0.1841
-0.00
(-0.43%)
After hours: May 30 at 7:50:17 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
481
420
442
14
22
Cost of Revenue
48
42
30
161
1,560
Gross Profit
433
378
412
-147
-1,538
Operating Expense
12,516
11,621
17,597
22,642
27,728
Operating Income
-12,083
-11,243
-17,185
-22,789
-29,266
Net Non Operating Interest Income Expense
-71
-10
347
0
--
Other Income Expense
-3,442
-2,249
-53,734
-4,073
2,009
Pretax Income
-15,596
-13,502
-70,572
-26,862
-27,257
Tax Provision
2,417
3,141
0
3
4
Net Income Common Stockholders
-23,171
-21,801
-71,372
-26,865
-25,070
Diluted NI Available to Com Stockholders
-23,171
-21,801
-71,372
-26,865
-25,070
Basic EPS
-6.68
-6.68
-129.88
-259.80
-2.48k
Diluted EPS
-6.68
-6.68
-129.88
-259.80
-2.48k
Basic Average Shares
4,227.2680
3,263.5860
549.5070
103.3820
10.1100
Diluted Average Shares
4,227.2680
3,263.5860
549.5070
103.3820
10.1100
Total Operating Income as Reported
-12,202
-11,243
-78,119
-26,961
-29,266
Total Expenses
12,564
11,663
17,627
22,803
29,288
Net Income from Continuing & Discontinued Operation
-18,013
-16,643
-70,572
-26,865
-25,070
Normalized Income
-17,918.9900
-16,643
-9,638
-23,569.1200
-28,737.7900
Interest Income
66
81
347
0
--
Interest Expense
137
91
0
--
--
Net Interest Income
-71
-10
347
0
--
EBIT
-15,459
-13,411
-70,572
-22,789
-29,266
EBITDA
-13,341
-11,302
-68,497
-22,368
-27,701
Reconciled Cost of Revenue
48
42
30
161
1,560
Reconciled Depreciation
2,118
2,109
2,075
421
1,565
Net Income from Continuing Operation Net Minority Interest
-18,013
-16,643
-70,572
-26,865
-27,261
Total Unusual Items Excluding Goodwill
-119
0
-60,934
-4,172
2,023
Total Unusual Items
-119
0
-60,934
-4,172
2,023
Normalized EBITDA
-13,222
-11,302
-7,563
-18,196
-29,724
Tax Rate for Calcs
0.0002
0.0002
0
0.0002
0.0003
Tax Effect of Unusual Items
-24.9900
0
0
-876.1200
546.2100
12/31/2021 - 9/27/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BBLG Bone Biologics Corporation
0.8801
+3.57%
 
BJDX Bluejay Diagnostics, Inc.
1.5900
+1.92%
 
TIVC Tivic Health Systems, Inc.
4.1300
-1.67%
 
NUWE Nuwellis, Inc.
0.8600
-7.53%
 
ALUR Allurion Technologies Inc.
2.6600
+1.14%
 
XAIR Beyond Air, Inc.
0.1824
-4.00%
 
WOK WORK Medical Technology Group LTD
0.8970
+3.10%
 
ICCM IceCure Medical Ltd
1.0500
+1.94%
 
NPCE NeuroPace, Inc.
13.22
+0.84%
 
NMTC NeuroOne Medical Technologies Corporation
0.6111
-5.14%